Lynn P Coates-Leisen, NP
Nurse Practitioner · Thousand Oaks
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lynn P Coates-Leisen’s office at (805) 719-1700 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$13,043
Medicare paid this office $13,043 for 53 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 42 | $5,821 | $72 |
| Long return visit (40+ min) | 21 | $4,559 | $117 |
| Short return visit (20+ min) | 12 | $1,006 | $48 |
Who their Medicare patients are
53 Original Medicare patients in 2024. Average age 72 · Women 66% · Health risk score 0.63. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 60% · Coronary heart disease 23%.
The office billed $36,557, Medicare allowed $19,791 and paid $13,043; for 158 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 53 | 158 | 72 | 0.63 | $36,557 | $13,043 |
| 2023 | 46 | 151 | 73 | 0.75 | $32,729 | $12,991 |
| 2022 | 38 | 94 | 74 | 0.57 | $18,839 | $8,162 |
| 2021 | 23 | 33 | 74 | 0.72 | $5,075 | $2,561 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Long return visit (40+ min) | 23 | $5,277 | $123 |
| Return visit (30+ min) | 38 | $5,119 | $78 |
2022: 2 services
| Return visit (30+ min) | 30 | $4,368 | $84 |
| Long return visit (40+ min) | 12 | $1,971 | $123 |
2021: 1 service
| Return visit (30+ min) | 16 | $1,416 | $71 |
Drugs they prescribed that Part D paid
$112,899
Pharmacies billed $112,899 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
489 generic and 120 brand-name prescriptions · $112,899 in drug cost · 18 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 33 | $39,757 | $1,205 |
| Rybelsus | 18 | $21,434 | $1,191 |
| Synthroid | 14 | $3,091 | $221 |
| NP Thyroid | 29 | $1,568 | $54 |
| Estradiol | 20 | $1,403 | $70 |
See all 16 drugs
| Ozempic | 33 | $39,757 | $1,205 |
| Rybelsus | 18 | $21,434 | $1,191 |
| Synthroid | 14 | $3,091 | $221 |
| NP Thyroid | 29 | $1,568 | $54 |
| Estradiol | 20 | $1,403 | $70 |
| Estradiol (Twice Weekly) | 12 | $1,309 | $109 |
| Liothyronine | 12 | $706 | $59 |
| Ezetimibe | 14 | $571 | $41 |
| Rosuvastatin | 43 | $539 | $13 |
| Levothyroxine | 39 | $464 | $12 |
| Metformin Hcl Er | 23 | $444 | $19 |
| Losartan | 37 | $250 | $7 |
| Omeprazole | 27 | $214 | $8 |
| Metformin | 32 | $184 | $6 |
| Lisinopril | 18 | $150 | $8 |
| Alprazolam | 13 | $25 | $2 |
Year by year
| 2024 | 641 | 44 | None | 19% | $112,899 |
| 2023 | 549 | 33 | 0% (0) | 17% | $79,079 |
| 2022 | 468 | 49 | None | 10% | $40,599 |
| 2021 | 685 | 90 | None | 12% | $64,237 |
| 2020 | 756 | 102 | 3% (22) | 20% | $82,580 |
| 2019 | 571 | 77 | 7% (41) | 21% | $46,010 |
| 2018 | 259 | 45 | 9% (22) | None | $12,142 |
| 2017 | 193 | 23 | 11% (22) | 24% | $10,261 |
| 2016 | 56 | 20 | None | None | $1,672 |
| 2015 | 39 | 16 | None | None | $856 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Rybelsus | 20 | $19,026 | $951 |
| Synthroid | 19 | $3,334 | $175 |
| Armour Thyroid | 12 | $1,589 | $132 |
| NP Thyroid | 20 | $1,383 | $69 |
| Rosuvastatin | 30 | $543 | $18 |
| Metformin | 44 | $467 | $11 |
| Losartan | 25 | $441 | $18 |
| Omeprazole | 24 | $433 | $18 |
| Testosterone Cypionate | 12 | $422 | $35 |
| Levothyroxine | 23 | $417 | $18 |
| Lisinopril | 20 | $357 | $18 |
| Metformin Hcl Er | 15 | $333 | $22 |
| Ezetimibe | 11 | $324 | $29 |
| Naproxen | 12 | $92 | $8 |
2022: 13 drugs
| Synthroid | 18 | $2,419 | $134 |
| Rosuvastatin | 30 | $661 | $22 |
| Losartan | 35 | $353 | $10 |
| Levothyroxine | 22 | $327 | $15 |
| Carisoprodol | 14 | $273 | $19 |
| Metformin | 26 | $213 | $8 |
| Metformin Hcl Er | 13 | $184 | $14 |
| Tamsulosin | 21 | $165 | $8 |
| Lisinopril | 20 | $131 | $7 |
| Montelukast | 12 | $102 | $8 |
| Omeprazole | 18 | $78 | $4 |
| Oxybutynin Chloride | 12 | $54 | $4 |
| Escitalopram | 12 | $38 | $3 |
2021: 19 drugs
| Synthroid | 18 | $2,383 | $132 |
| NP Thyroid | 19 | $2,065 | $109 |
| Liothyronine | 34 | $1,437 | $42 |
| Rosuvastatin | 16 | $943 | $59 |
| Levothyroxine | 34 | $920 | $27 |
| Losartan | 32 | $587 | $18 |
| Gabapentin | 11 | $540 | $49 |
| Anastrozole | 15 | $322 | $21 |
| Metformin | 33 | $299 | $9 |
| Omeprazole | 17 | $238 | $14 |
| Carisoprodol | 12 | $217 | $18 |
| Pioglitazone | 15 | $198 | $13 |
| Oxybutynin Chloride | 14 | $178 | $13 |
| Lisinopril | 27 | $175 | $6 |
| Escitalopram | 11 | $161 | $15 |
| Tamsulosin | 13 | $137 | $11 |
| Metformin Hcl Er | 16 | $131 | $8 |
| Atorvastatin | 17 | $117 | $7 |
| Spironolactone | 12 | $70 | $6 |
2020: 23 drugs
| Trulicity | 17 | $19,512 | $1,148 |
| Victoza 3-Pak | 12 | $11,943 | $995 |
| Januvia | 12 | $10,143 | $845 |
| Liothyronine | 51 | $2,921 | $57 |
| Progesterone | 17 | $1,002 | $59 |
| NP Thyroid | 19 | $866 | $46 |
| Synthroid | 18 | $640 | $36 |
| Losartan | 29 | $500 | $17 |
| Levothyroxine | 29 | $465 | $16 |
| Rosuvastatin | 21 | $348 | $17 |
| Ezetimibe | 13 | $286 | $22 |
| Metformin | 33 | $261 | $8 |
| Atorvastatin | 17 | $218 | $13 |
| Gabapentin | 15 | $216 | $14 |
| Estradiol | 14 | $191 | $14 |
| Pioglitazone | 18 | $179 | $10 |
| Metformin Hcl Er | 12 | $156 | $13 |
| Anastrozole | 16 | $137 | $9 |
| Simvastatin | 17 | $114 | $7 |
| Amlodipine Besylate | 11 | $85 | $8 |
| Escitalopram | 18 | $84 | $5 |
| Tamsulosin | 14 | $83 | $6 |
| Lisinopril | 12 | $63 | $5 |
2019: 19 drugs
| Trulicity | 12 | $8,845 | $737 |
| Oxycontin | 11 | $7,366 | $670 |
| Liothyronine | 37 | $3,125 | $84 |
| Rosuvastatin | 22 | $1,719 | $78 |
| Progesterone | 19 | $1,014 | $53 |
| Synthroid | 17 | $657 | $39 |
| Oxycodone | 22 | $646 | $29 |
| Levothyroxine | 32 | $457 | $14 |
| Ezetimibe | 15 | $361 | $24 |
| Pioglitazone | 18 | $295 | $16 |
| Losartan | 17 | $162 | $10 |
| Estradiol | 12 | $156 | $13 |
| Paroxetine | 11 | $152 | $14 |
| Atorvastatin | 16 | $119 | $7 |
| Metformin | 32 | $117 | $4 |
| Hydrochlorothiazide | 13 | $55 | $4 |
| Clopidogrel | 13 | $55 | $4 |
| Meclizine | 11 | $41 | $4 |
| Alprazolam | 15 | $32 | $2 |
2018: 7 drugs
| Rosuvastatin | 13 | $701 | $54 |
| Liothyronine | 11 | $285 | $26 |
| Levothyroxine | 22 | $261 | $12 |
| Clopidogrel | 15 | $175 | $12 |
| Paroxetine | 12 | $150 | $13 |
| Metformin | 24 | $85 | $4 |
| Alprazolam | 13 | $38 | $3 |
2017: 8 drugs
| Premarin | 14 | $4,072 | $291 |
| Oxycodone | 11 | $290 | $26 |
| Levothyroxine | 17 | $196 | $12 |
| Paroxetine | 12 | $142 | $12 |
| Hydrochlorothiazide | 14 | $47 | $3 |
| Metformin | 12 | $33 | $3 |
| Metformin Hcl Er | 11 | $27 | $2 |
| Lisinopril | 13 | $25 | $2 |
Money from drug and device companies
$16 in 2025
| 2025 | 1 | 1 | None | $16 |
| 2024 | 4 | 4 | None | $343 |
| 2023 | 6 | 10 | None | $847 |
| 2022 | 5 | 7 | None | $345 |
| 2021 | 5 | 12 | None | $289 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $16 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-05-30 | Ubrelvy | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $343
| Inari Medical | Flowtriever Catheter, S | $167 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $135 | 1 payment
|
| Lilly USA | Zepbound | $23 | 1 payment
|
| Novo Nordisk | Wegovy | $18 | 1 payment
|
2023: $847
| Novo Nordisk | Wegovy | $233 | 4 payments
|
| Microtransponder | None | $151 | 1 payment
|
| Inspire Medical Systems | Inspire | $141 | 1 payment
|
| GlaxoSmithKline | Shingrix | $122 | 1 payment
|
| Lilly USA | Mounjaro | $107 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $93 | 1 payment
|
2022: $345
| Lilly USA | Mounjaro | $148 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $143 | 2 payments
|
| Abbvie | Ubrelvy | $22 | 1 payment
|
| Antares Pharma | Nocdurna | $18 | 1 payment
|
| Bausch Health US | Aplenzin | $13 | 1 payment
|
2021: $289
| Amgen | Aimovig | $123 | 3 payments
|
| Lilly USA | Trulicity | $95 | 5 payments
|
| Bausch Health US | Aplenzin | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $20 | 1 payment
|
| Novo Nordisk | Wegovy | $15 | 1 payment
|
Professional record
- NPI
- 1134523558
- Licence
- CA 95001441
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 1429 E Thousand Oaks Blvd # 108, Thousand Oaks, CA, 91362
- NPI first listed
- 2014-10-14
- NPI last updated
- 2025-04-09
- NPI record certified
- 2025-04-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
This office lists an electronic records connection.